Katia Karalis's Biography

Katia Karalis, Executive Vice President of Research, Emulate, Inc.

Dr. Katia Karalis is the Vice President of Research at Emulate, Inc. Based on their Organs-on-Chips technology platform, the company is developing a new living human system that combines cell biology within micro-engineered environments - for researchers to accurately understand how different diseases, medicines, chemicals and foods will affect human health. Karalis’ career spans continents, academics and industry. Prior to joining Emulate she was an Assistant Professor of Pediatrics at Harvard Medical School as well as a Visiting Scholar at the Wyss Institute for Biologically Inspired Engineering at Harvard University. She is affiliated with the Division of Endocrinology of Children's Hospital, Harvard Medical School, and TU Dresden, Medical School, in Germany. As well she is a part of the Biomedical Research Foundation of the Academy of Athens, Greece. After her academic career training in basic Endocrinology at Cedars Sinai-UCLA and the NIH, she studied Clinical Molecular Genetics at Harvard Medical School. She joined the faculty of the Department of Medicine, Children’s Hospital Boston at Harvard Medical School. Karalis was recruited to set up the Developmental Biology Section of the Biomedical Research Foundation of the Academy of Athens (BRFAA). Karalis’ 30 years of faculty appointments, membership in medical societies and grant review activities has been at the cutting edge of Human Genetic Research, endocrine, liver and gastrointestinal studies. Her numerous honors and prizes include the Fogarty Fellowship (US Government), Fellow, Institute for Advancement of Sciences, Warwick University, UK and Honorary Affiliate TUM Dresden, FDR. Karalis received both her MD and PhD from University of Athens, Greece. Her Post-Doctoral training was in Endocrinology at NIH, Bethesda, MD and Children’s Hospital, Boston. As well her Clinical Molecular Genetics post-doctoral training was in the Harvard Medical School Genetics Training Program with her Clinical Cytogenetics Training at Brigham and Women’s Hospital, Boston. She has authored over 50 papers in peer-reviewed publications.